A detailed history of Ubs Asset Management Americas Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 153,152 shares of TNDM stock, worth $6.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
153,152
Previous 103,779 47.58%
Holding current value
$6.49 Million
Previous $3.67 Million 67.94%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$30.43 - $53.43 $1.5 Million - $2.64 Million
49,373 Added 47.58%
153,152 $6.17 Million
Q1 2024

May 15, 2024

BUY
$22.09 - $35.41 $249,815 - $400,451
11,309 Added 12.23%
103,779 $3.67 Million
Q4 2023

Feb 14, 2024

SELL
$14.28 - $31.03 $38,227 - $83,067
-2,677 Reduced 2.81%
92,470 $2.74 Million
Q3 2023

Nov 13, 2023

BUY
$19.33 - $36.22 $61,740 - $115,686
3,194 Added 3.47%
95,147 $1.98 Million
Q1 2023

May 15, 2023

BUY
$35.86 - $46.5 $128,558 - $166,702
3,585 Added 4.06%
91,953 $3.73 Million
Q4 2022

Feb 14, 2023

BUY
$35.49 - $56.15 $209,745 - $331,846
5,910 Added 7.17%
88,368 $3.97 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $510,898 - $805,224
-11,675 Reduced 12.4%
82,458 $3.95 Million
Q2 2022

Aug 12, 2022

SELL
$53.22 - $123.09 $116,179 - $268,705
-2,183 Reduced 2.27%
94,133 $5.57 Million
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $653,930 - $963,277
6,418 Added 7.14%
96,316 $11.2 Million
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $577,782 - $749,043
-4,889 Reduced 5.16%
89,898 $13.5 Million
Q3 2021

Nov 15, 2021

BUY
$93.51 - $129.4 $149,148 - $206,393
1,595 Added 1.71%
94,787 $11.3 Million
Q2 2021

Aug 16, 2021

BUY
$77.0 - $100.19 $578,270 - $752,426
7,510 Added 8.76%
93,192 $9.08 Million
Q1 2021

May 14, 2021

SELL
$81.28 - $104.34 $10 Million - $12.9 Million
-123,245 Reduced 58.99%
85,682 $7.56 Million
Q4 2020

Mar 01, 2021

BUY
$86.4 - $121.75 $492,825 - $694,462
5,704 Added 2.81%
208,927 $20 Million
Q3 2020

Nov 13, 2020

BUY
$95.43 - $116.09 $298,886 - $363,593
3,132 Added 1.57%
203,223 $23.1 Million
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $852,469 - $1.4 Million
14,196 Added 7.64%
200,091 $19.8 Million
Q1 2020

May 15, 2020

SELL
$47.37 - $90.04 $2.14 Million - $4.06 Million
-45,079 Reduced 19.52%
185,895 $12 Million
Q4 2019

Feb 14, 2020

BUY
$53.13 - $71.19 $9.32 Million - $12.5 Million
175,380 Added 315.47%
230,974 $13.8 Million
Q3 2019

Nov 14, 2019

BUY
$57.11 - $73.3 $494,915 - $635,217
8,666 Added 18.47%
55,594 $3.28 Million
Q2 2019

Aug 15, 2019

BUY
$54.41 - $71.7 $313,836 - $413,565
5,768 Added 14.01%
46,928 $0
Q1 2019

May 14, 2019

BUY
$32.25 - $73.56 $101,168 - $230,757
3,137 Added 8.25%
41,160 $0
Q4 2018

Feb 13, 2019

BUY
$28.45 - $40.65 $1.08 Million - $1.55 Million
38,023 New
38,023 $1.44 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.72B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.